Baillie Gifford reports 4.3% AEHR Test stake
Baillie Gifford & Co has reported a passive stake in AEHR Test Systems’ common stock below the 5% threshold.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Baillie Gifford & Co has reported a passive stake in AEHR Test Systems’ common stock below the 5% threshold. The firm beneficially owns 1,290,734 shares, representing 4.3% of the class, with sole voting and dispositive power over all of these shares.
Baillie Gifford & Co, an investment adviser based in Scotland, states that the AEHR shares were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of the company or participating in any control-related transactions.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stake does Baillie Gifford & Co hold in AEHR Test Systems (AEHR)?
Is Baillie Gifford & Co’s AEHR (AEHR) position passive or activist?
Why did Baillie Gifford & Co file an amended Schedule 13G/A for AEHR?
What does AEHR’s Schedule 13G/A say about Baillie Gifford & Co’s regulatory status?
AI-generated analysis. How Rhea-AI works. Not financial advice.